Source: Annual Congress 2011 - Knowing COPD by heart: a relationship beyond comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Anzueto (San Antonio, United States of America). The impact of cardiovascular drugs in COPD. Annual Congress 2011 - Knowing COPD by heart: a relationship beyond comorbidity

Member's Comments

No comment yet.

Related content which might interest you: ß2-adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities Source: Eur Respir Monogr 2020; 88: 229-237 Year: 2020 Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Impact of cardiovascular comorbidities on COPD exacerbations Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 The impact of airway infection on cardiovascular risk during COPD exacerbations Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012 No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 The association between COPD and cardiovascular disorders Source: International Congress 2017 – COPD and comorbid cardiovascular diseases Year: 2017 Using cardioselective beta-blockers in patients with cardiovascular diseases and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005 Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD Source: Eur Respir J 2010; 35: 1003-1021 Year: 2010 The impact of insulin-sensitizers on lung function in COPD Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016 Year: 2017 CPAP therapy in OSA patients: The effects on healthcare use and medical costs related to cardio- and cerebrovascular diseases Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 COPD exacerbations: impact and prevention Source: Breathe 2013; 9: 434-440 Year: 2013 Is there a strong relationship between COPD and cardiovascular diseases? Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010